IRRAS AB announced that Fredrik Alpsten, Chief Financial Officer, will leave IRRAS to pursue another opportunity outside of the company. However, he will remain at IRRAS until July 31 and will continue to support the company to ensure a seamless transition of responsibilities. Furthermore, Lance Boling, Vice President, Product Development, will revert to a consultant position for the company, a role he previously held since 2013 before joining the management group at IRRAS in 2017.

Effective June 24, 2019, there will be a single IRRAS management group, which will replace the previous structure with both executive and extended management teams. The management team will consist of the following persons: Kleanthis G. Xanthopoulos as President & CEO, Sabina Berlin as CFO, Will Martin as Chief Commercial Officer, Adam Sampson as Vice President, Product Excellence, Vinny Podichetty as Vice President, Clinical, Regulatory Affairs & Quality, Kellie Fontes as Senior Director, Human Capital. Mrs. Berlin, who is promoted to CFO, has been with IRRAS since 2014 and was previously Vice President, Finance, and deputy CFO. Kleanthis G. Xanthopoulos, President & CEO will take over the responsibility for investor relations.

Adam Sampson, Vice President, Product Excellence, will assume responsibility for IRRAS' new product development. Additionally, David Asbury, former Director of R&D at the recently acquired InnerSpace Neuro Solutions, is consulting with the company to complement the R&D team.